Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Craftport Cannabis Corp Com C.BBT


Primary Symbol: BHHKF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
Benchmark Botanics Inc through its subsidiaries, operates as a producer of medical cannabis. The company provides financing, partnership opportunities and acquisition offers to licensed producers and ancillary businesses within the cannabis industry. It operates approximately 12,000 square foot production facility in Peachland, British Columbia.


OTCPK:BHHKF - Post by User

Craftport Cannabis Corp Com
Bullboard Posts
User Avatar Image
(27)
•••
Post by STOCKRUSon May 07, 2019 10:48pm
37 Views
Post# 29722842

CANNABIS NEWS - Benchmark Signs Strategic China Cooperation

CANNABIS NEWS - Benchmark Signs Strategic China Cooperation Vancouver, B.C. May 7, 2019 – Benchmark Botanics, Inc. (CSE: BBT) (FSE: BBW) (OTC: BHHKF) ("Benchmark" or the "Company") a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has signed a non-binding letter of intent of strategic cooperation with China-based Zhejiang Yatai Pharmaceutical Co., Ltd. (“Zhejiang Yatai “), a publicly listed company on the Shenzhen Stock Exchange (stock code: 002370), to promote and conduct research and development, production, extraction and the commercial application of CBD and its derivative products for medical applications. Benchmark and Zhejiang Yatai agree to create, develop and market a variety of high content cannabinoid based (“CBD”) pharmaceuticals, natural health products and cosmetics for international markets.

https://benchmarkbotanics.com/investors/news/news-2019/83-benchmark-signs-a-letter-of-intent-of-strategic-cooperation-with-china-based-zejiang-yatai-pharmaceutical.html
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities